BRTX BioRestorative Therapies, Inc. Quick Ratio

This daily price chart for BioRestorative Therapies (BRTX) reflects asset dynamics where the indicator stands at 2.39. Biomaterial production is automated using robotic environmental control systems. Business development relies on university partnerships and the acquisition of patents to advance ThermoStem. Meanwhile, BioRestorative Therapies (BRTX) remains largely insulated from external economic crises, focusing instead on clinical trial results and the launch of new products.

BioRestorative Therapies, Inc. (BRTX) Quick Liquidity: for the period 07/04/2022 - 10/29/2026

Summary analytical data breakdowns for BioRestorative Therapies (BRTX)

- share price and expert price forecast:

Stock Price biorestorative.com|BRTX - Consensus Target

- market capitalization data:

Market Capitalization BioRestorative|BRTX - Total Enterprise Value

- balance sheet net asset value indicators:

Net Assets per Single Share BioRestorative Therapies|BRTX - Company Book Value|Market Value to Book Value Ratio biorestorative.com|BRTX - Aggregate Company Assets

- company liabilities and liquidity data:

- earnings and market multiples details:

BRTX - Final Profit

Fundamental valuation:BioRestorative Therapies Inc - BRTX

Manufactured product of BioRestorative Therapies

The quick ratio measures an issuer's ability to meet short-term obligations using its most liquid assets, completely excluding slow-moving inventories. By analyzing solvency dynamics without inventory holdings, an investor assesses the risk of cash flow gaps, which is critical for BioRestorative Therapies (BRTX) when financing costly developments in personalized cell therapy and the treatment of metabolic disorders.

Competitors of BioRestorative Therapies (BRTX)